0001209191-21-060230.txt : 20211012
0001209191-21-060230.hdr.sgml : 20211012
20211012163024
ACCESSION NUMBER: 0001209191-21-060230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211008
FILED AS OF DATE: 20211012
DATE AS OF CHANGE: 20211012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crystal Adam
CENTRAL INDEX KEY: 0001825445
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39567
FILM NUMBER: 211318879
MAIL ADDRESS:
STREET 1: C4 THERAPEUTICS, INC.
STREET 2: 490 ARSENAL WAY, SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: C4 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475617627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 231-0700
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-08
0
0001662579
C4 Therapeutics, Inc.
CCCC
0001825445
Crystal Adam
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY #200
WATERTOWN
MA
02472
0
1
0
0
Chief Medical Officer
Common Stock
2021-10-08
4
M
0
10000
6.49
A
10000
D
Stock Option (Right to Buy)
6.49
2021-10-08
4
M
0
10000
0.00
D
2029-04-08
Common Stock
10000
132292
D
25% of this option vested and became exercisable on February 14, 2020, with the remainder vesting in 16 equal quarterly installments thereafter.
/s/ Jolie M. Siegel, Attorney-in-Fact
2021-10-12